ATyr Pharma ROA 2014-2021 | LIFE

Current and historical return on assets (ROA) values for ATyr Pharma (LIFE) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
ATyr Pharma ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2021-09-30 $-0.03B $0.12B -44.94%
2021-06-30 $-0.03B $0.05B -62.70%
2021-03-31 $-0.03B $0.06B -54.35%
2020-12-31 $-0.02B $0.04B -34.97%
2020-09-30 $-0.02B $0.04B -37.78%
2020-06-30 $-0.02B $0.05B -35.16%
2020-03-31 $-0.02B $0.05B -34.97%
2019-12-31 $-0.02B $0.04B -53.63%
2019-09-30 $-0.02B $0.04B -48.98%
2019-06-30 $-0.03B $0.05B -47.17%
2019-03-31 $-0.03B $0.05B -50.22%
2018-12-31 $-0.03B $0.05B -52.51%
2018-09-30 $-0.04B $0.06B -52.88%
2018-06-30 $-0.04B $0.07B -52.28%
2018-03-31 $-0.05B $0.08B -55.90%
2017-12-31 $-0.05B $0.09B -60.65%
2017-09-30 $-0.05B $0.09B -64.90%
2017-06-30 $-0.05B $0.06B -70.75%
2017-03-31 $-0.06B $0.07B -66.07%
2016-12-31 $-0.06B $0.08B -60.73%
2016-09-30 $-0.06B $0.09B -56.61%
2016-06-30 $-0.06B $0.10B -47.74%
2016-03-31 $-0.05B $0.12B -40.07%
2015-12-31 $-0.05B $0.13B -38.84%
2015-09-30 $-0.04B $0.14B -39.47%
2015-06-30 $-0.03B $0.15B -56.41%
2015-03-31 $-0.03B $0.06B -138.27%
2014-12-31 $-0.03B $0.02B -476.19%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.224B $0.010B
aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.477B 7.93
Bio-Rad Laboratories (BIO.B) United States $23.034B 46.74
QIAGEN (QGEN) Netherlands $12.874B 21.80
Biohaven Pharmaceutical Holding (BHVN) United States $7.457B 0.00
Arcus Biosciences (RCUS) United States $3.257B 0.00
Emergent Biosolutions (EBS) United States $2.378B 8.55
Myovant Sciences (MYOV) United Kingdom $1.780B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.529B 0.00
Zymeworks (ZYME) Canada $0.908B 0.00
Ambrx Biopharma (AMAM) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.345B 0.00
Enzo Biochem (ENZ) United States $0.164B 16.09